Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna-Karin Hamberg

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Clinical Biochemistry|February 8, 2026
Inter-laboratory variability in vancomycin measurement in an external quality assessment scheme 2016-2025Anders Larsson, Jonathan Cedernaes, Mats B Eriksson, et al.
European Journal of Clinical Pharmacology|January 12, 2013
Warfarin dose prediction in children using pharmacometric bridging--comparison with published pharmacogenetic dosing algorithmsAnna-Karin Hamberg, Lena E Friberg, Katarina Hanséus, et al.
Frontiers in Genetics|October 3, 2022
Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic eventsSofia Attelind, Pär Hallberg, Mia Wadelius, et al.
British Journal of Clinical Pharmacology|October 18, 2022
General clinical and methodological considerations on the extrapolation of pharmacokinetics and optimization of study protocols for small molecules and monoclonal antibodies in childrenNaïm Bouazza, Aristides Dokoumetzidis, Catherijne A J Knibbe, et al.
The Pharmacogenomics Journal|November 2, 2019
CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysisMasanobu Takeuchi, Tohru Kobayashi, Tina Biss, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical Biochemistry|February 8, 2026
Inter-laboratory variability in vancomycin measurement in an external quality assessment scheme 2016-2025Anders Larsson, Jonathan Cedernaes, Mats B Eriksson, et al.
European Journal of Clinical Pharmacology|January 12, 2013
Warfarin dose prediction in children using pharmacometric bridging--comparison with published pharmacogenetic dosing algorithmsAnna-Karin Hamberg, Lena E Friberg, Katarina Hanséus, et al.
Frontiers in Genetics|October 3, 2022
Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic eventsSofia Attelind, Pär Hallberg, Mia Wadelius, et al.
British Journal of Clinical Pharmacology|October 18, 2022
General clinical and methodological considerations on the extrapolation of pharmacokinetics and optimization of study protocols for small molecules and monoclonal antibodies in childrenNaïm Bouazza, Aristides Dokoumetzidis, Catherijne A J Knibbe, et al.
The Pharmacogenomics Journal|November 2, 2019
CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysisMasanobu Takeuchi, Tohru Kobayashi, Tina Biss, et al.
Pageof 2